Cilostazol for Prevention of Recurrent Stroke Trial

NCT07174414 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Stroke Recurrence
Myocardial Infarction
Vascular Death
Ischemic Stroke
TIA (Transient Ischemic Attack)
Stroke (CVA) or Transient Ischemic Attack
Recurrent Stroke

Interventions

DRUG: Cilostazol 100 mg
DRUG: Placebo

Sponsor

Stanford University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]